Review: could Hydrochlorothiazide cause Hyperparathyroidism Secondary?


Hyperparathyroidism secondary is found among people who take Hydrochlorothiazide, especially for people who are female, 50-59 old , have been taking the drug for < 1 month, also take medication Aspirin, and have Renal failure chronic . We study 68,532 people who have side effects while taking Hydrochlorothiazide from FDA and social media. Among them, 6 have Hyperparathyroidism secondary. Find out below who they are, when they have Hyperparathyroidism secondary and more.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Hydrochlorothiazide has active ingredients of hydrochlorothiazide. It is often used in high blood pressure. (latest outcomes from Hydrochlorothiazide 88,934 users)

Hyperparathyroidism Secondary

Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary) has been reported by people with high blood pressure, osteoporosis, colonoscopy, depression, hyperphosphataemia (latest reports from 10,628 Hyperparathyroidism secondary patients).

On Oct, 28, 2016

68,532 people reported to have side effects when taking Hydrochlorothiazide.
Among them, 6 people (0.01%) have Hyperparathyroidism Secondary

Number of reports submitted per year:

Could Hydrochlorothiazide cause Hyperparathyroidism secondary?

Time on Hydrochlorothiazide when people have Hyperparathyroidism Secondary *:

  • < 1 month: 50 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 50 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Hyperparathyroidism Secondary when taking Hydrochlorothiazide *:

  • female: 66.67 %
  • male: 33.33 %

Age of people who have Hyperparathyroidism Secondary when taking Hydrochlorothiazide *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 66.67 %
  • 60+: 33.33 %

Top conditions involved for these people *:

  • Renal Failure Chronic (2 people, 33.33%)
  • Schizophrenia (1 person, 16.67%)
  • Plasma Cell Myeloma (1 person, 16.67%)
  • Immunodeficiency (1 person, 16.67%)
  • Hypertension (1 person, 16.67%)

Top co-used drugs for these people *:

  • Aspirin (4 people, 66.67%)
  • Norvasc (3 people, 50.00%)
  • Fosinopril Sodium (2 people, 33.33%)
  • Eprex (2 people, 33.33%)
  • Aranesp (2 people, 33.33%)

Top other side effects for these people *:

  • Oedema Peripheral (3 people, 50.00%)
  • Fatigue (3 people, 50.00%)
  • Cellulitis (3 people, 50.00%)
  • Renal Impairment (2 people, 33.33%)
  • Acute Prerenal Failure (2 people, 33.33%)

* Approximation only. Some reports may have incomplete information.

** Reports from social media are used.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have Hyperparathyroidism secondary when taking Hydrochlorothiazide?

Browse all side effects of Hydrochlorothiazide

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Hyperparathyroidism secondary

Hyperparathyroidism secondary

Could your condition cause Hyperparathyroidism secondary

Hyperparathyroidism secondary

Related studies

Can you answer these questions?

More questions for: Hydrochlorothiazide, Hyperparathyroidism secondary

You may be interested in these reviews

More reviews for: Hydrochlorothiazide, Hyperparathyroidism secondary

NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.